Safety and Pharmacodynamic Study of a New Formulation, AGI - 101H Vaccine in the Treatment of Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients
- Status
- TERMINATED
- Phase
- PHASE2
MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines
- Status
- COMPLETED
- Phase
- PHASE1
Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Temzolomide and Gleevec in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2